NCT03774901View on ClinicalTrials.gov

Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma

PHASE2UnknownINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 12, 2019

Primary Completion Date

September 22, 2024

Study Completion Date

September 22, 2024

Conditions
Penile CancerPenile NeoplasmsPenile Squamous Cell Carcinoma
Interventions
DRUG

Avelumab

intravenous 10 mg/kg every 2 weeks

Trial Locations (1)

25000

RECRUITING

Antoine THIERY VUILLEMIN, Besançon

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Centre Hospitalier Universitaire de Besancon

OTHER